Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.

Add Yahoo as a preferred source to see more of our stories on Google. Demis Hassabis speaks during the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 20, 2026.

In 2024, Demis Hassabis won a Nobel Prize in chemistry for his work in predicting protein structures through his company, Isomorphic Labs. The lab, which broke off from Google's DeepMind in 2021, ...

Isomorphic Labs has raised $600m in its first external funding round as it pushes forward with artificial intelligence (AI)-driven drug discovery. Thrive Capital led the financing round, with ...

Dr. James McCaffrey presents a complete end-to-end demonstration of linear regression with pseudo-inverse training implemented using JavaScript. Compared to other training techniques, such as ...

A research team at the City University of New York and the University of Texas at Austin has discovered a way to make previously hidden states of light, known as dark excitons, shine brightly, and ...

Ready for a master's that makes a difference? Miami University's Advanced Inquiry Program (AIP) is an innovative online degree, integrating flexible courses with unparalleled experiential learning at ...

About Advanced Micro Devices Inc. Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and ...

While earlier stages of ovarian cancer are easier to treat than advanced stages, early stages cause very few noticeable symptoms. This isn’t the case for advanced, or late-stage, ovarian cancer.

Google DeepMind, the artificial intelligence company behind the popular AlphaFold tool, has published the next generation of the application’s protein structure prediction software. The new tool can ...

Subscribe to our weekly newsletter for the latest in industry news, expert insights, dedicated information security content and online events.